| Date Initiated by Firm | July 18, 2008 |
| Date Posted | October 27, 2008 |
| Recall Status1 |
Terminated 3 on August 24, 2009 |
| Recall Number | Z-0174-2009 |
| Recall Event ID |
49360 |
| Product Classification |
Lancet - Product Code FMK
|
| Product | Premier Value Lancing Device. UPC Code: 840986016707, The Package Includes: 1 Lancing Device, 1 Clear Cap and 5 Premier Value Ultra Thin Lancets, Distributed by: Chain Drug Consortium, LLC, Boca Raton, FL 33431.
Lancing Device intended to be used by diabetes patients that require a drop of capillary blood for testing. |
| Code Information |
Lot Numbers: M057030, and M057022; Unit numbers: L339011, L339011, L339011, and L339011, |
| FEI Number |
3011617315
|
Recalling Firm/ Manufacturer |
Facet Technologies
101 Liberty Industrial Pkwy
McDonough
GA
30253-7556
|
| For Additional Information Contact | Scott Haygood 770-898-3223 |
Manufacturer Reason for Recall | The Alternate Site Cap was not included in the package as indicated on the labeling. |
FDA Determined Cause 2 | Error in labeling |
| Action | The consignees were notified by letter on/about 7/18/2008. The Return Material Authorization number was communicated to the customer. They were asked to place the items on hold and Can Am will obtain any quantities. The Returned Product Mechanics Process will: Inventory will be sent back to Facet in two stages, Inventory on hand at Cimetra will be sent back to Facet, Inventory received back from customers will be sent back to Facet in one shipment 30-60 days after notice. Inventory received back after this second shipment will be destroyed. |
| Quantity in Commerce | 2976 units |
| Distribution | Nationwide--GA and FL. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
|